Loading
Latest filing published 17 Apr 2026 for Lixte Biotechnology Holdings, INC.. Read the official filing
No signal scores available.
Lourdes Felix discloses dealings in 3 companies, chiefly BioCorRx Inc., La Rosa Holdings Corp. and Lixte Biotechnology Holdings, Inc. We count 3 filings; the first trade dates from 29 September 2023 and the latest from 15 April 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 17 April 2026, the filings show a share grant in Lixte Biotechnology Holdings, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations